Pegadricase clinical trials
Also written SEL-037 and Uricase-PEG 20.
- studies test it
- 5
- open now
- 0
- in phase 3
- 0
- first study started
- 2009
How each study uses pegadricase is sorted by a rule, right about nine times in ten. Readers can ask us to read every study one by one.Ask us to read each study
Approvals
The first approval found in each region, with its record
- United States
- Not in FDA's approval records
- European Union
- Not in EMA's list of EU-wide authorizations
From FDA's Drugs@FDA and Purple Book (through openFDA) and the European Medicines Agency, files of Sept 2026 and 27 Oct 2026. National approvals in Europe and other countries are not included. How this is worked out
How studies write it
Studies that test it under each name
Studies by the year they started
5 studies that test it; most in 2009 (2)
| Year | Studies |
|---|---|
| 2009 | 2 |
| 2015 | 2 |
| 2016 | 1 |
By phase
A phase 1/2 study counts in both.
What it is tested for
Each study’s main condition, where its own words name it, so a study counts once.
Who runs them
Industry 5 · Other 0
Often tested with
Tested in the same studies.
Studies
Open first, then newest update. How each study uses pegadricase is read from its arms, and is right about nine times in ten. Ask us to read each study. These are the studies that list it as an intervention; a search of ClinicalTrials.gov also finds studies that mention it only in a description, such as earlier treatment.
Testing it · 5
- Multi-Dose Safety/Pharmacodynamic Study of SEL-212/SEL-037 in Subjects With Symptomatic Gout & Elevated Blood Uric AcidCompletedPhase 2Selecta Biosciences, Inc.NCT02959918Written as SEL-037How we know
- Safety and Pharmacodynamics of SEL-212 (Pegsiticase + SEL-110) in Subjects With Elevated Blood Uric Acid LevelsCompletedPhase 1Selecta Biosciences, Inc.NCT02648269Written as SEL-037How we know
- Safety and Pharmacodynamics of SEL-037 (Pegsiticase) in Subjects With Elevated Blood Uric Acid LevelsCompletedPhase 1Selecta Biosciences, Inc.NCT02464605Written as SEL-037 (pegsiticase)How we know
- Safety and Efficacy Study of Intravenous Uricase-PEG 20Status unknownPhase 1EnzymeRxNCT01021241Written as Uricase-PEG 20How we know
- Safety and Efficacy Study of Intramuscular Uricase-PEG 20Status unknownPhase 1EnzymeRxNCT01038947Written as Uricase-PEG 20How we know
Codes
What other systems call pegadricase · ClinicalTrials.gg INT014962
- UNII (FDA) 50XB37EKN8PEGADRICASEConfirmed FDA, Wikidata
- Wikidata Q27260829pegadricaseConfirmed FDA, Wikidata
- NCI Thesaurus C166797PegadricaseOne source FDA
- DrugBank DB15129One source Wikidata
| System | Code | Name there | Checked by |
|---|---|---|---|
| UNII (FDA) | 50XB37EKN8 | PEGADRICASE | Confirmed FDA, Wikidata |
| Wikidata | Q27260829 | pegadricase | Confirmed FDA, Wikidata |
| NCI Thesaurus | C166797 | Pegadricase | One source FDA |
| DrugBank | DB15129 | — | One source Wikidata |
“Confirmed” means two independent publishers link the code to this drug; “one source”, one does and its name agrees.